EU TRANSPARENCY REGISTER · 430642397869-57 · Luxembourg

Innovative Medicines for Luxembourg ASBL

IML

Category

Trade and business associations

Country

Luxembourg

Luxembourg

Entity form

ASBL

Stated objectives

The Innovative Medicines for Luxembourg Asbl (IML) represents the research-based pharmaceutical industry in Luxembourg. As the voice of the sector, IML fosters a healthcare environment that promotes therapeutic innovation and ensures that p…

As declared by the registrant. Truncated to 240 characters; full text on the upstream profile.

Official profile

The full record on the Joint Transparency Register carries financial information (lobby budget, EU funding received), the list of named accredited representatives, declared interests of those persons, and a history of meetings with Commission officials.

Registered

2025-04-17

Last updated

2026-05-04

Other Trade and business associations in Luxembourg

Other registered organisations in Luxembourg

Frequently asked questions

What is this organisation?
Innovative Medicines for Luxembourg ASBL (IML) is an interest representative listed in the EU Joint Transparency Register under ID 430642397869-57. Entity form: ASBL.
What category is it registered under?
It is registered under the category "Trade and business associations".
Which country is it based in?
The organisation is based in Luxembourg, Luxembourg.
What are its stated goals?
As declared by the registrant: The Innovative Medicines for Luxembourg Asbl (IML) represents the research-based pharmaceutical industry in Luxembourg. As the voice of the sector, IML fosters a healthcare environment that promotes therapeutic innovation and ensures that p…
Where can I find its EU Transparency Register entry?
The full register entry — including lobby budget, EU funding received, accredited representatives and Commission meetings — is available on the EU Transparency Register under ID 430642397869-57.

Source: EU Joint Transparency Register (Council / Commission / Parliament) · refreshed 2026-06-30 · Commission Reuse Decision 2011/833/EU